GSK3174998 Alone and With Pembrolizumab in Participants With Advanced Solid Tumors (ENGAGE-1)
Clinical trial NCT02528357 · COMPLETED
Trial details
- NCT number
- NCT02528357
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-09-11
- Primary completion
- 2020-04-29
- Enrollment
- 141
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.